EndoChoice (GI) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
EndoChoice Announces Third Quarter 2015 Financial Results
November 5, 2015 7:00 AM ESTALPHARETTA, Ga., Nov. 5, 2015 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE:Â GI) announced today financial results for the third quarter 2015.
Highlights
Total revenue of $18.4 million, up 30% year-over-year (32% in constant currency) Installed base of Fuse®  now exceeds 100 systems Pathology revenue accelerating; 23% growth in specimens processed and 8% growth in number of customers year-over-year International revenue up 188% year-over-year, now 12% of total revenue compared to 5% in Q3 2014 Updated full year 2015 financial guidanceMark Gilreath, Founder and Chief Executive Officer of EndoChoice, said, "We delivered strong results in the... More
